NASDAQ: PCRXPacira Biosciences Inc Stock Ownership - Who owns Pacira Biosciences?
Insider buying vs selling
Have Pacira Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Abraham Ceesay | Director | 2025-09-04 | 2,354 | $27.19 | $64.01kSell |
| Marcelo Bigal | Director | 2025-08-07 | 4,912 | $23.67 | $116.27kSell |
| Jonathan Slonin | Chief Medical Officer | 2025-08-01 | 315 | $22.07 | $6.95kSell |
| Kristen Williams | Chief Administrative Officer | 2025-06-04 | 14,376 | $26.24 | $377.23kSell |
| Lauren Riker | Senior Vice President Finance | 2025-06-04 | 5,578 | $26.21 | $146.20kSell |
| Jonathan Slonin | Chief Medical Officer | 2025-06-03 | 5,084 | $26.40 | $134.22kSell |
| Kristen Williams | Chief Administrative Officer | 2025-06-03 | 6,162 | $26.40 | $162.68kSell |
| Lauren Riker | Senior Vice President Finance | 2025-06-03 | 3,374 | $26.40 | $89.07kSell |
| Jonathan Slonin | Chief Medical Officer | 2025-01-06 | 879 | $18.40 | $16.17kSell |
| Frank D. Lee | Chief Executive Officer | 2025-01-02 | 9,375 | $18.33 | $171.84kSell |
PCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PCRX insiders and whales buy or sell their stock.
PCRX Shareholders
What type of owners hold Pacira Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 17.35% | 7,796,029 | $206.67M | Institution |
| Vanguard Group Inc | 12.03% | 5,405,964 | $143.31M | Institution |
| Orbimed Advisors LLC | 11.74% | 5,274,941 | $139.84M | Insider |
| Andreas Wicki | 9.09% | 4,085,359 | $108.30M | Insider |
| Carl L. Gordon | 6.30% | 2,828,941 | $75.00M | Insider |
| Mpm Bioventures IV Qp LP | 6.21% | 2,790,479 | $73.98M | Insider |
| Vaughn M. Kailian | 6.21% | 2,790,479 | $73.98M | Insider |
| Renaissance Technologies LLC | 5.33% | 2,395,601 | $63.51M | Institution |
| D E Shaw Co Inc | 5.01% | 2,253,365 | $59.74M | Institution |
| Hbm Healthcare Investments Cayman Ltd | 4.97% | 2,233,993 | $59.22M | Insider |
PCRX vs Pharmaceutical Stocks
Pacira Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.